Overview
Lobbying Costs
500,000€ - 599,999€
Financial year: Jan 2023 - Dec 2023
Lobbyists (Full time equivalent)
3.5 Fte (5)
Lobbyists with EP accreditation
2
High-level Commission meetings
11
Lobbying Costs over the years
-
Info
Affordable Medicines Europe
EU Transparency Register
509882515669-01 First registered on 20 Jan 2015
Goals / Remit
Affordable Medicines Europe represents Europe’s licensed parallel distribution industry, an integral part of the European pharmaceutical market that adds value to society by introducing price competition – especially for patented medicines – and a supplementary layer of product safety. In this our members work every fay to make medicines more affordable for European healthcare systems and patients.
Our industry has an annual turnover of 5.5 billion Euro. We have more than 120 companies in 23 EU/EEA Member States as members. These members account for approximately 80% of the total parallel import market volume in the EU/EEA. Membership of Affordable Medicines Europe is exclusive to companies holding a wholesale (GDP) license (export and import). All importing members furthermore are GMP licensed.Main EU files targeted
Distribution and access to medicines
How to alleviate shortages of medicines
Affordability of medicines
EU Pharma Strategy
Implementation of the Directive on Falsified MedicinesAddress
Head Office
Rue des Deux Eglises 26
Brussels 1000
BELGIUMEU Office
Rue des Deux Eglises 26
Brussels 1000
BELGIUMWebsite
-
People
Total lobbyists declared
5
Employment time Lobbyists 100% 3 25% 2 Lobbyists (Full time equivalent)
3.5
Lobbyists with EP accreditation
All Lobbyists with EP accreditation over time
2 accreditations were / are live (in bold) for the selected state of 27 Apr 2024
Name Start date End Date Matteo POIDOMANI 05 Oct 2023 04 Oct 2024 Kasper ERNEST 06 Oct 2023 04 Oct 2024 Mr Kasper Ernest 06 Oct 2023 15 Apr 2024 Mr Matteo POIDOMANI 05 Oct 2023 15 Apr 2024 Mr Matteo POIDOMANI 13 Oct 2022 05 Oct 2023 Mr Kasper Ernest 12 Oct 2022 06 Oct 2023 Matteo POIDOMANI 02 Oct 2021 01 Oct 2022 Mr Kasper Ernest 09 Jul 2021 09 Jul 2022 Mr Daniel SCHUBEL 29 May 2020 29 May 2021 Mr Kasper Ernest 20 Feb 2020 20 Feb 2021 Ms Olga RUPPERT 06 Sep 2019 05 Sep 2020 Mr Escolastico AGUIAR LOSADA 19 Mar 2019 19 Feb 2020 Mr Kasper Ernest 09 Nov 2018 09 Nov 2019 Mr Oliver LUKSIC 13 Sep 2016 10 Sep 2017 Complementary Information
None declared
Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
Trade and business associations
-
Networking
Affiliation
Affordable Medicines Europe is a member of:
- the European Medicines Verification Organisation (EMVO)
- the Alliance for Safe Online Pharmacy (ASOP EU)
- the Federation of European and International Associations (FAIB)
- Friends of EuropeMember organisations
None declared
-
Financial Data
Interests represented
Promotes their own interests or the collective interests of their members
Closed financial year
Jan 2023 - Dec 2023
Lobbying costs for closed financial year
500,000€ - 599,999€
Major contributions in closed year
None declared
Intermediaries for closed year
None declaredIntermediaries for current year
None declaredClosed year Costs
500,000€ - 599,999€
Other financial info
None declared
-
EU Structures
Groups (European Commission)
None declared
Groups (European Parliament)
N/A
Communication activities
None declared
Other activities
None declared
Meetings
Meetings
11 meetings found. Download meetings
The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.
-
Date 08 Mar 2023 Location Brussels Subject Revision of the Pharmaceutical Package Cabinet Cabinet of Executive Vice-President Margrethe Vestager Portfolio Europe Fit for Digital Age Attending - Simon Genevaz (Cabinet member)
-
Date 07 Mar 2023 Location Brussels Subject EU pharmaceutical legislation-and discuss specifications the Environmental Risk Assessment (ERA) Cabinet Cabinet of President Ursula von der Leyen Portfolio President Attending - Peter van Kemseke (Cabinet member)
-
Date 07 Mar 2023 Location Brussels, Belgium Subject Upcoming revision of the EU pharmaceutical legislation; the critical point of the public service obligation proposed for manufacturers (Article 39(2)); the need for a European level public service obligation; the electronic patient leaflet; Cabinet Cabinet of Commissioner Janusz Wojciechowski Portfolio Agriculture Attending - Joanna Stawowy (Cabinet member)
-
Date 02 Feb 2021 Location Videoconference Subject Resilience of the EU pharmaceutical supply chain Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Eszter Batta (Cabinet member)
- Pauline Weinzierl (Cabinet member)
-
Date 28 Aug 2018 Location BRUSSELS Subject pharma sector - medicines Cabinet Cabinet of Commissioner Elżbieta Bieńkowska Portfolio Internal Market, Industry, Entrepreneurship and SMEs Attending - Rolf Carsten Bermig (Cabinet member)
- Kaius Kristian Hedberg (Cabinet member)
Other Lobbyists -
Date 18 Jul 2018 Location Brussels, Belgium Subject Parallel import of medicines Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Annika Nowak (Cabinet member)
-
Date 13 Oct 2017 Location Brussels Subject Parallel trade Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Annika Nowak (Cabinet member)
-
Date 08 Dec 2016 Location Brussels Subject new export ban list Poland Cabinet Cabinet of Commissioner Elżbieta Bieńkowska Portfolio Internal Market, Industry, Entrepreneurship and SMEs Attending - Rolf Carsten Bermig (Cabinet member)
-
Date 11 Jul 2016 Location Brussels Subject Shortages of medicines Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Vytenis Andriukaitis (Commissioner)
- Annika Nowak (Cabinet member)
-
Date 18 May 2015 Location Brussels Subject Trade in drugs DG Health and Food Safety Attending - Ladislav Miko (acting Director-General)
-
Date 06 Mar 2015 Location Brussels Subject Falsified medicines Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Annika Nowak (Cabinet member)